Companies join on eye disease diagnostic:
This article was originally published in Clinica
Executive Summary
Welch Allyn and Applied Spectral Imaging are to jointly develop portable retinal imaging products for the detection of retinal diseases that may lead to blindness. The companies will use Applied's proprietary SpectraCube spectral imaging technology. The technology separates the spectral content of light reacting with retinal tissue to provide a multi-dimensional data base which can be used for image enhancement and analysis. Migdal Ha'emek, Israel-based Applied Spectral will get product development milestones. Welch Allyn, of Skaneateles Falls, New York, will have marketing rights to products resulting from the deal.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.